jCyte Announces Promotion of Dr. Shannon Blalock to Chief Executive Officer
Search jobs jCyte Announces Promotion of Dr. Shannon Blalock to Chief Executive Officer - Dr. Blalock brings more than 25 years of commercialization and operational expertise as jCell therapy advances toward its pivotal Phase 3 clinical trial program. NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte Inc., a biotech company dedicated to improving the lives of patients with retinal degenerative diseases, today announced the Board of Directors has promoted Dr. Shannon Blalock to Chief Executive Officer and an elected member of the Board. Dr. Blalock joined jCyte last year a...